triclosan has been researched along with Epilepsy in 4 studies
Epilepsy: A disorder characterized by recurrent episodes of paroxysmal brain dysfunction due to a sudden, disorderly, and excessive neuronal discharge. Epilepsy classification systems are generally based upon: (1) clinical features of the seizure episodes (e.g., motor seizure), (2) etiology (e.g., post-traumatic), (3) anatomic site of seizure origin (e.g., frontal lobe seizure), (4) tendency to spread to other structures in the brain, and (5) temporal patterns (e.g., nocturnal epilepsy). (From Adams et al., Principles of Neurology, 6th ed, p313)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (75.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (25.00) | 2.80 |
| Authors | Studies |
|---|---|
| De la Rosa, V | 1 |
| Guzmán-Hernández, ML | 1 |
| Carrillo, E | 1 |
| GLOOR, P | 1 |
| DOMINO, EF | 1 |
| HRBEK, J | 1 |
1 review available for triclosan and Epilepsy
| Article | Year |
|---|---|
[NEUROPHYSIOLOGY AS THE BASIS OF CLINICAL NEUROLOGY].
Topics: Epilepsy; History; Humans; Neurology; Neurophysiology; Physiology; Triclosan | 1963 |
3 other studies available for triclosan and Epilepsy
| Article | Year |
|---|---|
Triclosan is a KCNQ3 potassium channel activator.
Topics: Epilepsy; Humans; KCNQ Potassium Channels; KCNQ1 Potassium Channel; KCNQ2 Potassium Channel; KCNQ3 P | 2022 |
NEUROPHARMACOLOGIC BASIS OF DRUG TREATMENT OF EPILEPSY.
Topics: Autonomic Agents; Drug Therapy; Epilepsy; Neuropharmacology; Triclosan | 1964 |
[Pathophysiological basis and classification of epilepsy. Part II].
Topics: Epilepsy; Humans; Triclosan | 1960 |